IQ Micro announced today the successful completion of an important micro-fabricating program conducted by the Centre Suisse d'Electronique et de Microtechnique SA (CSEM) in Switzerland.
This technical breakthrough is significant because microchips containing thousands of invisible pumps can now be mass produced for a wide range of applications including lab-on-chip technology used to perform high-speed medical analysis.
Johnny Christiansen, president and CEO of IQ Micro said, "This success of our micro-fabricating program represents a major achievement for our company. To our knowledge this is a first in our industry. As a result, we are taking the necessary steps to protect this exciting, new technology. With a proven ability to micro-fabricate thousands of our "Invisible Pumps" on a single micro-chip, the mass production of complex microfluidic systems has been significantly simplified. We intend to proceed as quickly as possible to exploit this competitive advantage by entering into licensing arrangements involving multiple applications of this technology."
The rapidly emerging microfluidic industry has developed from the microchip industry. However, as opposed to the flow of electrical current through a silicon chip, microfluidic technology involves circuits of tiny chambers, channels and pumps that direct the flow of liquids on a single micro-chip. There are literally thousands of potential applications representing potentially billions of dollars in business. These include disease diagnostics, lab-on-a-chip technology, flat screen displays, electronics cooling, micro fuel cells, glucose monitoring and manufacturing process control, automated DNA analysis, drug development, enhanced battery life span and medical diagnostics.